Considerations When Analyzing the Methylation Status of PTEN Tumor Suppressor Gene
- 1 March 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 160 (3) , 795-800
- https://doi.org/10.1016/s0002-9440(10)64902-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Frequent Loss of PTEN Expression Is Linked to Elevated Phosphorylated Akt Levels, but Not Associated with p27 and Cyclin D1 Expression, in Primary Epithelial Ovarian CarcinomasThe American Journal of Pathology, 2001
- PTEN, a Protean Tumor SuppressorThe American Journal of Pathology, 2001
- Epigenetic PTEN Silencing in Malignant Melanomas without PTEN MutationThe American Journal of Pathology, 2000
- hMLH1 Promoter Hypermethylation Is an Early Event in Human Endometrial TumorigenesisThe American Journal of Pathology, 1999
- Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the BreastThe American Journal of Pathology, 1999
- A highly conserved processed PTEN pseudogene is located on chromosome band 9p21Oncogene, 1998
- Germline mutations in PTEN are present in Bannayan-Zonana syndromeNature Genetics, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Localization of the gene for Cowden disease to chromosome 10q22–23Nature Genetics, 1996